Jeffrey S. Hackman
CIK 1926254 · Chief Executive Officer · last filed 2026-10-13
Jeffrey S. Hackman is a Chief Executive Officer who has filed 17 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider was granted $12.3K of FENC on Oct 13, 2026. Across all open-market trades the lifetime net is +$202.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $709.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
FENC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 4650
WOBURN, MA 01801
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FENC | Chief Executive Officer | 69,685 | $10.18 | $709.4K | $104.6K | 13 | 2026-10-13 |
| Comera Life Sciences Holdings, Inc. (CMRAW) Delisted | See Remarks. | 47,600 | $0.02 | $919 | $98.1K | 4 | 2023-09-28 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-13 | FENC | Grant (A) | +2,224 | $12.3K | EDGAR |
| 2026-10-01 | FENC | Grant (A) | +1,159 | $0 | EDGAR |
| 2026-08-31 | FENC | Grant (A) | +1,159 | $0 | EDGAR |
| 2026-08-03 | FENC | Grant (A) | +1,159 | $0 | EDGAR |
| 2026-07-01 | FENC | Grant (A) | +1,159 | $0 | EDGAR |
| 2026-06-01 | FENC | Grant (A) | +1,159 | $0 | EDGAR |
| 2026-05-01 | FENC | Exer (M) | +1,159 | $0 | EDGAR |
| 2026-04-02 | FENC | Mixed | +31,797 | $0 | EDGAR |
| 2026-02-19 | FENC | Exer (M) | +13,710 | $0 | EDGAR |
| 2025-05-19 | FENC | Buy (P) | +15,000 | $104.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.